Treatment of Knee Osteochondral Lesions Using a Novel Clot of Autologous Plasma Rich in Growth Factors Mixed with Healthy Hyaline Cartilage Chips and Intra-Articular Injection of PRGF

<div>Composition of figures demonstrating the initial injury, surgical treatment, and postoperative MRI 6 months after surgery. (a) Preoperative sagittal T1-sequence MRI demonstrating an osteochondral injury (white arrow). (b) Intraoperative picture demonstrating the debrided defect in the lateral femoral condyle. The small picture shows the injury seen during the diagnostic arthroscopy. (c) Intraoperative picture demonstrating the filled defect after the autologous matrix had been applied. (d) Postoperative sagittal T1-sequence MRI demonstrating adequate filling and incorporation of the matrix in the lateral femoral condyle and absence of subchondral oedema (white arrow).</div>

Case Reports in Orthopedics

fig3

Figure 3

Figure 3: Treatment of Knee Osteochondral Lesions Using a Novel Clot of Autologous Plasma Rich in Growth Factors Mixed with Healthy Hyaline Cartilage Chips and Intra-Articular Injection of PRGF 

Figure 3 | Treatment of Knee Osteochondral Lesions Using a Novel Clot of Autologous Plasma Rich in Growth Factors Mixed with Healthy Hyaline Cartilage Chips and Intra-Articular Injection of PRGF 